Introductory CMC Analytical Studies and Lab Quality is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


18-19 May 2020
Radisson Blu Edwardian Kenilworth,

Introductory CMC Analytical Studies and Lab Quality

Gain an understanding and balanced view of the practical requirements for CMC studies to help with strategic decisions, budgets and timeframes on this 2-day course.

For biotech and biosimilar products

What will you learn?

Phase-specific requirements

Gain a comprehensive overview of the phase-specific requirements for CMC analytical characterisation, comparability, release and stability of biotechnology products

Product life cycle

Examine the different stages of the life cycle including pre-clinical, clinical trials, commercialisation and post-approval

Analytical considerations

Discuss analytical considerations for a wide variety of biopharmaceuticals including monoclonal antibodies, therapeutic proteins, gene therapy, vaccines, and complex products (e.g. antibody drug conjugates)

Product reference standards

Maintain product reference standards and design successful comparability tests

Comparability tests

Design and implement successful comparability tests for biosimilars

Product specifications

Learn to set meaningful product specifications, conduct forced degradation studies and manage tech transfer

Methods and protocol

Bridge changes in analytical methods and generate effective stability protocols

Lab quality practices

Assess critical elements of laboratory quality practices that significantly impact the reliability of test data from R&D through to current GMP will be illustrated

Who is this course for?

This training course is intended for the professional who is involved with stability testing for biotechnology products, directly or indirectly. Professionals from Pharmaceutical, Biotechnology, Drug Delivery and Medical Device companies should attend, such as, but not limited to:

  •  Stability Directors/ Supervisors/Managers/Analysts/Coordinators
  • Laboratory Supervisors/ Managers
  • Project Managers/Coordinators
  • Quality Control Analytical Chemists
  • Research and Development Chemists
  • Biostatisticians
  • LIMS Administrators
  • QA/QC Reviewers
  • Validation Scientists
  • Calibration/Metrology Groups
  • Internal or Independent Auditors
  • Manufacturing/Production Managers